Key Metrics
CiteScore 

7.8
H-Index 

74
Impact Factor 

< 5
SJR 

Q1Urology

SNIP 

1.72
Recommended pre-submission checks
Powered by 

Topics Covered on Prostate Cancer and Prostatic Diseases
Prostate Cancer and Prostatic Diseases Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | SPRINGERNATURE |
| Language | English |
| Frequency | Quarterly |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 1997 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Prostate Cancer and Prostatic Diseases ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Prostate Cancer and Prostatic Diseases
From fungus fighter to cancer slayer: itraconazole as a multifaceted candidate for drug-resistant prostate cancer.
- 6 Aug 2026
- Prostate cancer and prostatic diseases
Clinical and genomic determinants of extraordinary response and resistance to androgen receptor pathway inhibitors in men with metastatic androgen pathway modulator sensitive (APMS) prostate cancer.
- 5 Aug 2026
- Prostate cancer and prostatic diseases
Germline genetic risk and prostate cancer-specific mortality in a population-based incident cohort.
- 4 Aug 2026
- Prostate cancer and prostatic diseases
Prognostic value of cribriform pattern and intraductal carcinoma of the prostate after radical prostatectomy: A systematic review and meta-analysis using contemporary consensus recommendations.
- 3 Aug 2026
- Prostate cancer and prostatic diseases
Counseling is counseling is counseling is counseling - The evolution of LUTS/BPO care.
- 3 Aug 2026
- Prostate cancer and prostatic diseases
Long-term oncologic outcomes of patients with grade group 1 prostate cancer and pT3a disease on final pathology.
- 17 Jul 2026
- Prostate cancer and prostatic diseases
From fungus fighter to cancer slayer: itraconazole as a multifaceted candidate for drug-resistant prostate cancer.
- 6 Aug 2026
- Prostate cancer and prostatic diseases
Clinical and genomic determinants of extraordinary response and resistance to androgen receptor pathway inhibitors in men with metastatic androgen pathway modulator sensitive (APMS) prostate cancer.
- 5 Aug 2026
- Prostate cancer and prostatic diseases
Germline genetic risk and prostate cancer-specific mortality in a population-based incident cohort.
- 4 Aug 2026
- Prostate cancer and prostatic diseases
Prognostic value of cribriform pattern and intraductal carcinoma of the prostate after radical prostatectomy: A systematic review and meta-analysis using contemporary consensus recommendations.
- 3 Aug 2026
- Prostate cancer and prostatic diseases
Counseling is counseling is counseling is counseling - The evolution of LUTS/BPO care.
- 3 Aug 2026
- Prostate cancer and prostatic diseases
Long-term oncologic outcomes of patients with grade group 1 prostate cancer and pT3a disease on final pathology.
- 17 Jul 2026
- Prostate cancer and prostatic diseases